This topic contains a solution. Click here to go to the answer

Author Question: The client with COPD may have a decline in eating because of all of the following except: a. ... (Read 16 times)

justinmsk

  • Hero Member
  • *****
  • Posts: 524
The client with COPD may have a decline in eating because of all of the following except:
 a. decreased tolerance in ability to chew and swallow.
  b. nasal / abdominal breathing.
  c. altered taste and appetite.
  d. early satiety.

Question 2

The primary nutrition goal for a client with COPD is to:
 a. prevent fat redistribution as a side effect of corticosteroid therapy.
  b. stimulate immune system response.
  c. maintain body muscle mass.
  d. provide antioxidants.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

emily12345

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

b

Answer to Question 2

c




justinmsk

  • Member
  • Posts: 524
Reply 2 on: Aug 2, 2018
:D TYSM


softEldritch

  • Member
  • Posts: 334
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

Approximately 15–25% of recognized pregnancies end in miscarriage. However, many miscarriages often occur before a woman even knows she is pregnant.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

For a complete list of videos, visit our video library